Management Team
BOD
SAB
CAB
About Metabolic Diseases
Home
>
About
>
Board of Directors
>
Investors
Metabolex is privately held. We are supported by investors who have invested an aggregate of $117 million since August 2003. Our major investors include:
Alta Partners
KBC Funds
Alliance Bernstein
Merlin Biomed Group
Bay City Capital
Novo Ventures
Birchmere Ventures
Pictet Funds (LUX)
Biotech Turnaround Fund BV
T. Rowe Price
Charter Life Sciences
VantagePoint Ventures
Deerfield Management
Venrock Partners
Johnson & Johnson Development Corporation
Versant Ventures
